Similar articles

• Aminoguanidine, a potential drug for the treatment of diabetic complications.

  Wolffenbuttel BH, Huijberts MS. Wolffenbuttel BH, et al. Neth J Med. 1993 Jun;42(5-6):205-8. Neth J Med. 1993. PMID: 8377878 No abstract available.
• Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.

  Roufail E, Soulis T, Boel E, Cooper ME, Rees S. Roufail E, et al. Diabetologia. 1998 Dec;41(12):1419-25. doi: 10.1007/s001250051087. Diabetologia. 1998. PMID: 9867208
• Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.

  Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G. Soulis T, et al. Diabetologia. 1997 Oct;40(10):1141-51. doi: 10.1007/s001250050799. Diabetologia. 1997. PMID: 9349594
• Endothelial nitric oxide in diabetes mellitus: too much or not enough?

  Farkas K, Sármán B, Jermendy G, Somogyi A. Farkas K, et al. Diabetes Nutr Metab. 2000 Oct;13(5):287-97. Diabetes Nutr Metab. 2000. PMID: 11105972 Review.
• Nitric Oxide Therapy for Diabetic Wound Healing.

  Malone-Povolny MJ, Maloney SE, Schoenfisch MH. Malone-Povolny MJ, et al. Adv Healthc Mater. 2019 Jun;8(12):e1801210. doi: 10.1002/adhm.201801210. Epub 2019 Jan 15. Adv Healthc Mater. 2019. PMID: 30645055 Free PMC article. Review.